Kiromic BioPharma Inc. (KRBP)
undefined
undefined%
At close: undefined
0.00
-100.00%
After-hours Dec 31, 1969, 07:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18
Revenue - - - - - -
Cost of Revenue 2.80M 2.07M 469.80K 200.00K 87.50K 80.90K
Gross Profit -2.80M -2.07M -469.80K -200.00K -87.50K -80.90K
Operating Income -19.94M -31.11M -25.74M -19.20M -3.71M -3.18M
Interest Income - - - - - -
Pretax Income -20.95M -34.73M -25.59M -19.20M -3.73M -3.82M
Net Income -21.29M -38.18M -25.65M -19.20M -3.75M -3.82M
Selling & General & Admin 7.52M 17.19M 13.94M 14.14M 2.50M 1.76M
Research & Development 9.62M 13.92M 11.37M 5.05M 1.20M 1.42M
Other Expenses - - 53.40K - - -
Operating Expenses 19.94M 31.11M 25.31M 19.20M 3.71M 3.18M
Interest Expense -1.85M 166.50K 12.20K 3.30K 22.50K 633.10K
Selling & Marketing Expenses -2.80M - - - - -
Cost & Expenses 19.94M 31.11M 25.31M 19.20M 3.71M 3.18M
Income Tax - 3.45M 65.60K 3.30K 22.50K -80.24K
Shares Outstanding (Basic) 1.10M 544.53K 380.61K 242.83K 129.32K 117.76K
Shares Outstanding (Diluted) 1.10M 544.53K 380.61K 242.83K 129.32K 117.76K
EPS (Basic) -21.41 -70.12 -67.4 -79.08 -29 -32.4
EPS (Diluted) -21.41 -70.12 -67.4 -79.08 -29 -32.4
EBITDA -16.30M -32.50M -25.74M -19.00M -3.62M -3.10M
Depreciation & Amortization 2.80M 2.07M 469.80K 200.00K 87.50K 80.90K